CN Patent

CN108558653A — 赛乐西帕中间体及赛乐西帕的制备方法

Assigned to Hunan Huateng Pharmaceutical Co Ltd · Expires 2018-09-21 · 8y expired

What this patent protects

本发明公开了一种赛乐西帕中间体及赛乐西帕的制备方法，所述的中间体为化合物 和化合物 本发明提供的赛乐西帕的制备方法工艺设计合理，适合工业化放大生产。

USPTO Abstract

本发明公开了一种赛乐西帕中间体及赛乐西帕的制备方法，所述的中间体为化合物 和化合物 本发明提供的赛乐西帕的制备方法工艺设计合理，适合工业化放大生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN108558653A
Jurisdiction
CN
Classification
—
Expires
2018-09-21
Drug substance claim
No
Drug product claim
No
Assignee
Hunan Huateng Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.